Centre de recherche di Centre Hospitalier de i'Universite de Montreal

Montreal H2X 0A9

0 studies enrolling now · 1 studies all time

What they study most

Low Grade Ovarian Serous Adenocarcinoma, Ovarian Cancer

Studies at this site

• A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation — Running, not enrolling